CTNM Annual Cash & Cash Equivalents
$15.53 M
+$9.96 M+178.79%
31 December 2023
Summary:
As of January 23, 2025, CTNM annual cash & cash equivalents is $15.53 million, with the most recent change of +$9.96 million (+178.79%) on December 31, 2023. During the last 3 years, it has risen by +$10.90 million (+235.33%). CTNM annual cash & cash equivalents is now at all-time high.CTNM Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTNM Quarterly Cash And Cash Equivalents
$40.89 M
-$36.34 M-47.05%
30 September 2024
Summary:
As of January 23, 2025, CTNM quarterly cash and cash equivalents is $40.89 million, with the most recent change of -$36.34 million (-47.05%) on September 30, 2024. Over the past year, it has increased by +$25.36 million (+163.37%). CTNM quarterly cash and cash equivalents is now -47.05% below its all-time high of $77.23 million, reached on June 30, 2024.CTNM Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTNM Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +178.8% | +163.4% |
| 3 y3 years | +235.3% | +634.3% |
| 5 y5 years | +235.3% | +634.3% |
CTNM Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +235.3% | -47.0% | +634.3% |
| 5 y | 5-year | at high | +235.3% | -47.0% | +634.3% |
| alltime | all time | at high | +235.3% | -47.0% | +634.3% |
Contineum Therapeutics Class A Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $40.89 M(-47.1%) |
| June 2024 | - | $77.23 M(+374.9%) |
| Mar 2024 | - | $16.26 M(+4.8%) |
| Dec 2023 | $15.53 M | $15.53 M(-11.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $17.52 M(+214.6%) |
| Dec 2022 | $5.57 M(+20.3%) | - |
| Dec 2022 | - | $5.57 M |
| Dec 2021 | $4.63 M | - |
FAQ
- What is Contineum Therapeutics Class A annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Contineum Therapeutics Class A?
- What is Contineum Therapeutics Class A annual cash & cash equivalents year-on-year change?
- What is Contineum Therapeutics Class A quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Contineum Therapeutics Class A?
- What is Contineum Therapeutics Class A quarterly cash and cash equivalents year-on-year change?
What is Contineum Therapeutics Class A annual cash & cash equivalents?
The current annual cash & cash equivalents of CTNM is $15.53 M
What is the all time high annual cash & cash equivalents for Contineum Therapeutics Class A?
Contineum Therapeutics Class A all-time high annual cash & cash equivalents is $15.53 M
What is Contineum Therapeutics Class A annual cash & cash equivalents year-on-year change?
Over the past year, CTNM annual cash & cash equivalents has changed by +$9.96 M (+178.79%)
What is Contineum Therapeutics Class A quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CTNM is $40.89 M
What is the all time high quarterly cash and cash equivalents for Contineum Therapeutics Class A?
Contineum Therapeutics Class A all-time high quarterly cash and cash equivalents is $77.23 M
What is Contineum Therapeutics Class A quarterly cash and cash equivalents year-on-year change?
Over the past year, CTNM quarterly cash and cash equivalents has changed by +$25.36 M (+163.37%)